EVITA: Evaluation of VIP Feature in Pacemaker Patients
EVITA: Evaluation of VIP Feature in Pacemaker Patients
The primary efficacy objective of this clinical investigation is to demonstrate that the
 Ventricular Intrinsic Preference (VIP™) feature allows to reduce the medium- and long-term
 incidence of unnecessary ventricular pacing in patients with intact AV conduction.
Inclusion Criteria:

 -  Patient has an indication for implantation of a dual-chamber pacemaker;

 -  Patient is implanted or scheduled to be implanted with a St Jude Medical Victory
 pacemaker, or newer device with the same study relevant feature.

 Exclusion Criteria:

 -  Patient has persistent or permanent AF/AFl;

 -  Patient has permanent AV Block;

 -  Patient has a pacemaker replacement;

 -  Patient is in NYHA class IV;

 -  Patient is unable to attend the follow-up visits;

 -  Patient is pregnant;

 -  Patient is less than 18 years of age